Asher A Chanan Khan, MD

Professor, Jacksonville, FL, Hematology / Oncology / Cancer Center / Breast Clinic

EmailChanan-Khan.Asher@mayo.edu

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research activity per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Asher A Chanan Khan is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

12 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

VACCINE FOR PATIENTS WITH NON HODGKINS LYMPHOMA
Chanan Khan, A. A.
National Cancer Institute
Project: Research project
Therapeutic implication of CD38 in CLL
Chanan Khan, A. A. & Chini, E. N.
National Cancer Institute
Project: Research project
Phase 1/2 of AT-101 With Lenalidomide for Tx of Chronic Lymphocytic Leukemia
Chanan Khan, A. A.
National Institutes of Health
Project: Research project

11867 Citations
53 Scopus h-Index
154 Article
37 Review article
9 Letter
8 Chapter
More

Allogeneic hematopoietic cell transplantation is an effective treatment for patients with Richter syndrome: A systematic review and meta-analysis
Aulakh, S., Reljic, T., Yassine, F., Ayala, E., Chavez, J. C., Chanan-Khan, A., Pinilla-Ibarz, J., Kumar, A. & Kharfan-Dabaja, M. A., Mar 2021, In: Hematology/ Oncology and Stem Cell Therapy. 14, 1, p. 33-40 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
2 Scopus citations
A Panel Evaluation of the Changes in the General Public’s Social-Media-Following of United States’ Public Health Departments during COVID-19 Pandemic
Khokhar, A., Spaulding, A., Niazi, Z., Ailawadhi, S., Manochakian, R., Chanan-khan, A., Niazi, S. & Sher, T., 2021, In: Journal of Primary Care and Community Health. 12
Research output: Contribution to journal › Article › peer-review

Open Access
Atrial fibrillation in patients with chronic lymphocytic leukemia (CLL) treated with ibrutinib: risk prediction, management, and clinical outcomes
Archibald, W. J., Rabe, K. G., Kabat, B. F., Herrmann, J., Ding, W., Kay, N. E., Kenderian, S. S., Muchtar, E., Leis, J. F., Wang, Y., Chanan-Khan, A. A., Schwager, S. M., Koehler, A. B., Fonder, A. L., Slager, S. L., Shanafelt, T. D., Call, T. G. & Parikh, S. A., Jan 2021, In: Annals of hematology. 100, 1, p. 143-155 13 p.
Research output: Contribution to journal › Article › peer-review
1 Scopus citations
Awareness of myeloma care and the global impact of treatment: An international internet-based prospective study
Ailawadhi, S., Swaika, A., Advani, P., Hodge, D., Paulus, A., Khera, N. D., Hashmi, S. K., Alegria, V. R., Abdulazeez, M., Bodepudi, S., Jamwal, K., Roy, V., Sher, T., Chanan-Khan, A. & Ailawadhi, M., 2021, (Accepted/In press) In: Journal of Oncology Pharmacy Practice.
Research output: Contribution to journal › Article › peer-review
Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia
Parrondo, R. D., Moustafa, M. A., Reeder, C., Sher, T., Roy, V., Muchtar, E., Warsame, R., Alegria, V., Gonsalves, W., Dingli, D., Hayman, S., Kapoor, P., Chanan-Khan, A. A. & Ailawadhi, S., 2021, (Accepted/In press) In: Clinical Lymphoma, Myeloma and Leukemia.
Research output: Contribution to journal › Article › peer-review